ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,043,343 | +2040.0% | 38,443 | +2323.9% | 0.03% | +1550.0% |
| Q2 2023 | $48,754 | +68567.6% | 1,586 | -19.6% | 0.00% | 0.0% |
| Q1 2023 | $71 | -87.0% | 1,973 | -85.7% | 0.00% | -91.3% |
| Q4 2022 | $546 | -99.5% | 13,815 | +396.9% | 0.02% | +1050.0% |
| Q3 2022 | $112,000 | -57.4% | 2,780 | -55.5% | 0.00% | -66.7% |
| Q2 2022 | $263,000 | +14.8% | 6,245 | +6.0% | 0.01% | +200.0% |
| Q1 2022 | $229,000 | -64.1% | 5,889 | -63.2% | 0.00% | -81.8% |
| Q4 2021 | $638,000 | +1019.3% | 15,998 | +925.5% | 0.01% | +1000.0% |
| Q3 2021 | $57,000 | -95.1% | 1,560 | -94.5% | 0.00% | -96.7% |
| Q2 2021 | $1,172,000 | +501.0% | 28,607 | +539.8% | 0.03% | +900.0% |
| Q1 2021 | $195,000 | +89.3% | 4,471 | +117.4% | 0.00% | 0.0% |
| Q4 2020 | $103,000 | +390.5% | 2,057 | +312.2% | 0.00% | – |
| Q3 2020 | $21,000 | – | 499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |